Hubei Biocause Heilen Pharmaceutical (301211.SZ): Fiposidone tablets obtained drug registration certificate.

Hubei Biocause Heilen Pharmaceutical (301211.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the drug Febuxostat. Febuxostat is a xanthine oxidase inhibitor used primarily for long-term treatment of hyperuricemia and gout patients (including uric acid-lowering treatment after acute attacks of gouty arthritis).